Omni Medical Services (Omni) and NutraLife BioSciences Inc. (NutraLife) announce NutraLife to manufacture and provide finished CBD products for Omni’s new line of Omni CBD Solutions. Omni’s first products are 1,000 mg full spectrum spray tinctures and 500 mg topical lotions with the official launch planned for January 2020. Additional product lines scheduled for First Quarter include edibles and topicals with higher concentrations and a wide variety of terpenes. As part of launching its new line of CBD products, Omni plans further research with its patients to advance DNA testing that provides personalized profiles for the best CBD strains specifically for individual patients. The aim is to discover the precise CBD strains maximized for each patient. First up for retail stores, Omni has recently signed an agreement to sell its products at Charlotte CBD stores with three retail locations in North and South Carolina.